Currently, there are 2.94M common shares owned by the public and among those 2.92M shares have been available to trade.
The company’s stock has a 5-day price change of 23.64% and -75.27% over the past three months. CNSP shares are trading -77.41% year to date (YTD), with the 12-month market performance down to -99.74% lower. It has a 12-month low price of $0.77 and touched a high of $800.00 over the same period. CNSP has an average intraday trading volume of 501.11K shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by 29.63%, -19.63%, and -76.06% respectively.
Institutional ownership of Cns Pharmaceuticals Inc (NASDAQ: CNSP) shares accounts for 1.35% of the company’s 2.94M shares outstanding.
It has a market capitalization of $4.00M and a beta (3y monthly) value of 0.83. The earnings-per-share (ttm) stands at -$1367.97. Price movements for the stock have been influenced by the stock’s volatility, which stands at 31.89% over the week and 16.57% over the month.
Analysts forecast that Cns Pharmaceuticals Inc (CNSP) will achieve an EPS of 0 for the current quarter, 0 for the next quarter and 0 for current fiscal year. The lowest estimate earnings-per-share for the quarter is 0 while analysts give the company a high EPS estimate of 0. Earnings per share for the fiscal year are expected to decrease by -8.39%, and 96.18% over the next financial year. EPS should shrink at an annualized rate of 65.40% over the next five years, compared to 70.59% over the past 5-year period.
Ladenburg Thalmann coverage for the Cns Pharmaceuticals Inc (CNSP) stock in a research note released on August 24, 2020 offered a Buy rating with a price target of $11.
